-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PPG1qNlA2nr3hyRP7HImUHf6HqrvkuAZpzJNpAArFApPF38AAZ/KercxLP6Sl2FZ naRiVxyGgqqGDNMGszT2cw== 0001144204-02-001376.txt : 20021115 0001144204-02-001376.hdr.sgml : 20021115 20021115120910 ACCESSION NUMBER: 0001144204-02-001376 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20021115 GROUP MEMBERS: BRIANNE GOLDSTEIN GROUP MEMBERS: JACLYN BELSON GROUP MEMBERS: JOHNATHAN BELSON GROUP MEMBERS: JOSHUA GOLDSTEIN GROUP MEMBERS: MARJORIE BELSON GROUP MEMBERS: MAXINE BELSON GROUP MEMBERS: THE JEROME BELSON FOUNDATION GROUP MEMBERS: TOBY GOLDSTEIN SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ELITE PHARMACEUTICALS INC /DE/ CENTRAL INDEX KEY: 0001053369 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223542636 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-59693 FILM NUMBER: 02829026 BUSINESS ADDRESS: STREET 1: 165 LUDLOW AVENUE CITY: NORTHVALE STATE: NJ ZIP: 07647 BUSINESS PHONE: 2017502646 MAIL ADDRESS: STREET 1: 165 LUDLOW AVENUE CITY: NORTHVALE STATE: NJ ZIP: 07647 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BELSON JEROME CENTRAL INDEX KEY: 0000900685 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 495 BROADWAY 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10012 BUSINESS PHONE: 2129419500 MAIL ADDRESS: STREET 1: BELSON ENTERPRISES, INC. STREET 2: 495 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10012 SC 13D/A 1 doc1.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) ELITE PHARMACEUTICALS, INC. ---------------------------------------------- (Name of Issuer) Common Stock ----------------------------- (Title of Class of Securities) 28659T200 -------------- (CUSIP Number) Edward B. Winslow, Esq. Jacobs Persinger & Parker 77 Water Street, New York, New York 10005 212-344-1866 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) November 9, 1998 ------------------------------------------------------ (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box / /. NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Section 240.13d-7(b) for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SCHEDULE 13D CUSIP No. 28659T200 - --------------------------------------------------------------------- (1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Jerome Belson - --------------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A (a) / / MEMBER OF A GROUP (SEE INSTRUCTIONS) (b) /X/ - --------------------------------------------------------------------- (3) SEC USE ONLY - --------------------------------------------------------------------- (4) SOURCE OF FUNDS (SEE INSTRUCTIONS) PF - --------------------------------------------------------------------- (5) CHECK BOX IF DISCLOSURE OF LEGAL / / PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) Not applicable. - --------------------------------------------------------------------- (6) CITIZENSHIP OR PLACE OF ORGANIZATION USA - --------------------------------------------------------------------- NUMBER OF SHARES (7) SOLE VOTING POWER BENEFICIALLY OWNED BY EACH 791,200 REPORTING PERSON ---------------------------------------------- WITH (8) SHARED VOTING POWER 113,900 ---------------------------------------------- (9) SOLE DISPOSITIVE POWER 791,200 ---------------------------------------------- (10) SHARED DISPOSITIVE POWER 113,900 - --------------------------------------------------------------------- (11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 905,100 shares - --------------------------------------------------------------------- (12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) /X/ EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) - --------------------------------------------------------------------- (13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 9.02% - --------------------------------------------------------------------- (14) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN - --------------------------------------------------------------------- 2 SCHEDULE 13D CUSIP No. 28659T200 - --------------------------------------------------------------------- (1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Maxine Belson - --------------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A (a) / / MEMBER OF A GROUP (SEE INSTRUCTIONS) (b) /X/ - --------------------------------------------------------------------- (3) SEC USE ONLY - --------------------------------------------------------------------- (4) SOURCE OF FUNDS (SEE INSTRUCTIONS) PF - --------------------------------------------------------------------- (5) CHECK BOX IF DISCLOSURE OF LEGAL / / PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) Not applicable. - --------------------------------------------------------------------- (6) CITIZENSHIP OR PLACE OF ORGANIZATION USA - --------------------------------------------------------------------- NUMBER OF SHARES (7) SOLE VOTING POWER BENEFICIALLY OWNED BY EACH ---- REPORTING PERSON ---------------------------------------------- WITH (8) SHARED VOTING POWER 53,900 ---------------------------------------------- (9) SOLE DISPOSITIVE POWER --- ---------------------------------------------- (10) SHARED DISPOSITIVE POWER 53,900 - --------------------------------------------------------------------- (11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 53,900 shares - --------------------------------------------------------------------- (12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) /X/ EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) - --------------------------------------------------------------------- (13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.5% - --------------------------------------------------------------------- (14) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN - --------------------------------------------------------------------- 3 SCHEDULE 13D CUSIP No. 28659T200 - --------------------------------------------------------------------- (1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) The Jerome Belson Foundation - --------------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A (a) / / MEMBER OF A GROUP (SEE INSTRUCTIONS) (b) / / - --------------------------------------------------------------------- (3) SEC USE ONLY - --------------------------------------------------------------------- (4) SOURCE OF FUNDS (SEE INSTRUCTIONS) WC - --------------------------------------------------------------------- (5) CHECK BOX IF DISCLOSURE OF LEGAL / / PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) Not applicable. - --------------------------------------------------------------------- (6) CITIZENSHIP OR PLACE OF ORGANIZATION New York - --------------------------------------------------------------------- NUMBER OF SHARES (7) SOLE VOTING POWER BENEFICIALLY OWNED BY EACH 50,000 REPORTING PERSON ---------------------------------------------- WITH (8) SHARED VOTING POWER --- ---------------------------------------------- (9) SOLE DISPOSITIVE POWER 50,000 ---------------------------------------------- (10) SHARED DISPOSITIVE POWER --- - --------------------------------------------------------------------- (11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 50,000 shares - --------------------------------------------------------------------- (12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) / / EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) - --------------------------------------------------------------------- (13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.5% - --------------------------------------------------------------------- (14) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO - --------------------------------------------------------------------- 4 SCHEDULE 13D CUSIP No. 28659T200 - --------------------------------------------------------------------- (1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Brianne Goldstein - --------------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A (a) / / MEMBER OF A GROUP (SEE INSTRUCTIONS) (b) /X/ - --------------------------------------------------------------------- (3) SEC USE ONLY - --------------------------------------------------------------------- (4) SOURCE OF FUNDS (SEE INSTRUCTIONS) PF - --------------------------------------------------------------------- (5) CHECK BOX IF DISCLOSURE OF LEGAL / / PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) Not applicable. - --------------------------------------------------------------------- (6) CITIZENSHIP OR PLACE OF ORGANIZATION USA - --------------------------------------------------------------------- NUMBER OF SHARES (7) SOLE VOTING POWER BENEFICIALLY OWNED BY EACH --- REPORTING PERSON ---------------------------------------------- WITH (8) SHARED VOTING POWER 7,000 ---------------------------------------------- (9) SOLE DISPOSITIVE POWER --- ---------------------------------------------- (10) SHARED DISPOSITIVE POWER 7,000 - --------------------------------------------------------------------- (11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 7,000 shares - --------------------------------------------------------------------- (12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) / / EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) - --------------------------------------------------------------------- (13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.07% - --------------------------------------------------------------------- (14) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN - --------------------------------------------------------------------- 5 SCHEDULE 13D CUSIP No. 28659T200 - --------------------------------------------------------------------- (1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Toby Goldstein - --------------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A (a) / / MEMBER OF A GROUP (SEE INSTRUCTIONS) (b) /X/ - --------------------------------------------------------------------- (3) SEC USE ONLY - --------------------------------------------------------------------- (4) SOURCE OF FUNDS (SEE INSTRUCTIONS) PF - --------------------------------------------------------------------- (5) CHECK BOX IF DISCLOSURE OF LEGAL / / PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) Not applicable. - --------------------------------------------------------------------- (6) CITIZENSHIP OR PLACE OF ORGANIZATION USA - --------------------------------------------------------------------- NUMBER OF SHARES (7) SOLE VOTING POWER BENEFICIALLY OWNED BY EACH --- REPORTING PERSON ---------------------------------------------- WITH (8) SHARED VOTING POWER 5,000 ---------------------------------------------- (9) SOLE DISPOSITIVE POWER --- ---------------------------------------------- (10) SHARED DISPOSITIVE POWER 5,000 - --------------------------------------------------------------------- (11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 5,000 shares - --------------------------------------------------------------------- (12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) / / EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) - --------------------------------------------------------------------- (13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.05% - --------------------------------------------------------------------- (14) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN - --------------------------------------------------------------------- 6 SCHEDULE 13D CUSIP No. 28659T200 - --------------------------------------------------------------------- (1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Joshua Goldstein - --------------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A (a) / / MEMBER OF A GROUP (SEE INSTRUCTIONS) (b) /X/ - --------------------------------------------------------------------- (3) SEC USE ONLY - --------------------------------------------------------------------- (4) SOURCE OF FUNDS (SEE INSTRUCTIONS) PF - --------------------------------------------------------------------- (5) CHECK BOX IF DISCLOSURE OF LEGAL / / PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) Not applicable. - --------------------------------------------------------------------- (6) CITIZENSHIP OR PLACE OF ORGANIZATION USA - --------------------------------------------------------------------- NUMBER OF SHARES (7) SOLE VOTING POWER BENEFICIALLY OWNED BY EACH --- REPORTING PERSON ---------------------------------------------- WITH (8) SHARED VOTING POWER 5,000 ---------------------------------------------- (9) SOLE DISPOSITIVE POWER --- ---------------------------------------------- (10) SHARED DISPOSITIVE POWER 5,000 - --------------------------------------------------------------------- (11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 5,000 shares - --------------------------------------------------------------------- (12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) / / EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) - --------------------------------------------------------------------- (13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.05% - --------------------------------------------------------------------- (14) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN - --------------------------------------------------------------------- 7 SCHEDULE 13D CUSIP No. 28659T200 - --------------------------------------------------------------------- (1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Marjorie Belson - --------------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A (a) / / MEMBER OF A GROUP (SEE INSTRUCTIONS) (b) /X/ - --------------------------------------------------------------------- (3) SEC USE ONLY - --------------------------------------------------------------------- (4) SOURCE OF FUNDS (SEE INSTRUCTIONS) PF - --------------------------------------------------------------------- (5) CHECK BOX IF DISCLOSURE OF LEGAL / / PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) Not applicable. - --------------------------------------------------------------------- (6) CITIZENSHIP OR PLACE OF ORGANIZATION USA - --------------------------------------------------------------------- NUMBER OF SHARES (7) SOLE VOTING POWER BENEFICIALLY OWNED BY EACH --- REPORTING PERSON ---------------------------------------------- WITH (8) SHARED VOTING POWER 28,000 ---------------------------------------------- (9) SOLE DISPOSITIVE POWER --- ---------------------------------------------- (10) SHARED DISPOSITIVE POWER 28,000 - --------------------------------------------------------------------- (11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 28,000 shares - --------------------------------------------------------------------- (12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) / / EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) - --------------------------------------------------------------------- (13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.3% - --------------------------------------------------------------------- (14) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN - --------------------------------------------------------------------- 8 SCHEDULE 13D CUSIP No. 28659T200 - --------------------------------------------------------------------- (1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Jonathan Belson - --------------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A (a) / / MEMBER OF A GROUP (SEE INSTRUCTIONS) (b) /X/ - --------------------------------------------------------------------- (3) SEC USE ONLY - --------------------------------------------------------------------- (4) SOURCE OF FUNDS (SEE INSTRUCTIONS) PF - --------------------------------------------------------------------- (5) CHECK BOX IF DISCLOSURE OF LEGAL / / PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) Not applicable. - --------------------------------------------------------------------- (6) CITIZENSHIP OR PLACE OF ORGANIZATION USA - --------------------------------------------------------------------- NUMBER OF SHARES (7) SOLE VOTING POWER BENEFICIALLY OWNED BY EACH --- REPORTING PERSON ---------------------------------------------- WITH (8) SHARED VOTING POWER 7,500 ---------------------------------------------- (9) SOLE DISPOSITIVE POWER --- ---------------------------------------------- (10) SHARED DISPOSITIVE POWER 7,500 - --------------------------------------------------------------------- (11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 7,500 shares - --------------------------------------------------------------------- (12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) / / EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) - --------------------------------------------------------------------- (13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.08% - --------------------------------------------------------------------- (14) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN - --------------------------------------------------------------------- 9 SCHEDULE 13D CUSIP No. 28659T200 - --------------------------------------------------------------------- (1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Jaclyn Belson - --------------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A (a) / / MEMBER OF A GROUP (SEE INSTRUCTIONS) (b) /X/ - --------------------------------------------------------------------- (3) SEC USE ONLY - --------------------------------------------------------------------- (4) SOURCE OF FUNDS (SEE INSTRUCTIONS) PF - --------------------------------------------------------------------- (5) CHECK BOX IF DISCLOSURE OF LEGAL / / PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) Not applicable. - --------------------------------------------------------------------- (6) CITIZENSHIP OR PLACE OF ORGANIZATION USA - --------------------------------------------------------------------- NUMBER OF SHARES (7) SOLE VOTING POWER BENEFICIALLY OWNED BY EACH --- REPORTING PERSON ---------------------------------------------- WITH (8) SHARED VOTING POWER 7,500 ---------------------------------------------- (9) SOLE DISPOSITIVE POWER --- ---------------------------------------------- (10) SHARED DISPOSITIVE POWER 7,500 - --------------------------------------------------------------------- (11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 7,500 shares - --------------------------------------------------------------------- (12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) / / EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) - --------------------------------------------------------------------- (13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.08% - --------------------------------------------------------------------- (14) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN - --------------------------------------------------------------------- 10 AMENDMENT NO. 1 TO SCHEDULE 13D The Schedule 13D filed by Jerome Belson and Maxine Belson on October 6, 2000 is amended as follows: ITEM 2. IDENTITY AND BACKGROUND is hereby amended as follows: The following persons are added to the listing of persons filing this Schedule 13D: The Jerome Belson Foundation, which is a New York not-for-profit corporation formerly known as The Joseph Belsky Foundation (the "Foundation"), is organized for educational, charitable and scientific purposes. The Foundation's address is 495 Broadway, New York, New York 10012. Jerome Belson is the President of the Foundation. Certain information concerning the directors and executive officers of the Foundation is set forth in Annex I hereto. Brianne Goldstein, who is a housewife and the daughter of Jerome Belson. Her address is 22 A Putnam Green, Greenwich, CT 06830 Toby Goldstein, who is a public relations executive and a granddaughter of Jerome Belson. Her address is 22 A Putnam Green, Greenwich, CT 06830. Joshua Goldstein, who is an advertising executive and a grandson of Jerome Belson. His address is 5516 South Robertson - Apt. A., New Orleans, LA 70115. Marjorie Belson, who is a public school teacher and the daughter-in-law of Jerome Belson. Her address is 315 Ocean Parkway - Apt. 1P, Brooklyn, NY 11218. Jonathan Belson, who is a student and a grandson of Jerome Belson. His address is 444 East 86th Street - Apt. 12G, New York, NY 10028. Jaclyn Belson, who is a student and a granddaughter of Jerome Belson. Her address is 444 East 86th Street - Apt. 12G, New York, NY 10028. None of the Foundation, Brianne Goldstein, Toby Goldstein, Joshua Goldstein, Marjorie Belson, Jonathan Belson, or Jaclyn Belson, has, and to the best of the knowledge of the persons filing this Amendment, no person listed on 11 Annex I has, during the past five years been (i) convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors), or (ii) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction as a result of which such person was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. Brianne Goldstein, Toby Goldstein, Joshua Goldstein, Marjorie Belson, Jonathan Belson and Jaclyn Belson are United States citizens. The Foundation is a New York not-for-profit corporation. ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION is amended by adding thereto the following: The aggregate purchase price of the 535,200 shares of the Common Stock of the Company and 256,000 warrants to purchase such Common Stock reported in this Amendment as soley owned by Jerome Belson is $1,764,439, including brokerage commissions, the source of which was his personal funds. The aggregate purchase price of the 53,900 shares of the Common Stock of the Company reported in this Amendment as owned by Maxine Belson is $289,020, including brokerage commissions, the source of which was her personal funds. The aggregate purchase price of the 50,000 shares of the Common Stock of the Company reported in this Amendment as owned by the Foundation is $453,351, including brokerage commissions, the source of which was its capital. The aggregate purchase price of the 7,000 shares of the Common Stock of the Company reported in this Amendment as owned by Brianne Goldstein is $51,663, including brokerage commissions, the source of which was her personal funds. The aggregate purchase price of the 5,000 shares of the Common Stock of the Company reported in this Amendment as owned by Toby Goldstein is $39,076, including brokerage commissions, the source of which was her personal funds. 12 The aggregate purchase price of the 5,000 shares of the Common Stock of the Company reported in this Amendment as owned by Joshua Goldstein is $32,284, including brokerage commissions, the source of which was his personal funds. The aggregate purchase price of the 28,000 shares of the Common Stock of the Company reported in this Amendment as owned by Marjorie Belson is $112,465, including brokerage commissions, the source of which was her personal funds. The aggregate purchase price of the 5,000 shares of the Common Stock of the Company reported in this Amendment as owned by Jonathan Belson is $45,615, including brokerage commissions, the source of which was his personal funds. The aggregate purchase price of the 7,500 shares of the Common Stock of the Company reported in this Amendment as owned by Jaclyn Belson is $45,842, including brokerage commissions, the source of which was her personal funds. ITEM 4. PURPOSE OF TRANSACTION is amended to add thereto the following: The purchases of the shares reported in this Amendment No. 1 to Schedule 13D were made for the purpose of making an investment in the Company. Consistent with such purpose, Jerome Belson has had and expects to continue to have discussions with management of the Company concerning the Company and the investment of persons making this filing therein. Jerome Belson may also engage in such discussions with other shareholders of the Company. The persons making this filing may, in the future, purchase additional shares of the Common Stock of the Company depending on the price of the shares and circumstances at the time of such acquisitions, if any, are made. Alternatively, any of the persons making this filing may at any time determine to realize on such person's investment in the securities of the Company through their sale. The persons making this filing have no present plans or proposals to effect one or more of the transactions enumerated in paragraphs (b) to (j) of Item 4 of Schedule 13D. 13 ITEM 5. INTEREST IN SECURITIES OF THE ISSUER is amended to add thereto the following: The following table sets forth the beneficial ownership as of the date of filing of this Amendment of the Common Stock of the Company by the persons filing this Amendment.
Percent of Name No. of Shares Outstanding* - --------------------- ------------- ------------ Jerome Belson 905,100 (1) 9.02 The Jerome Belson Foundation, Inc. 50,000 (2) 0.5 Maxine Belson 53,900 (3) 0.5 Brianne Goldstein 7,000 (3) 0.07 Toby Goldstein 5,000 0.05 Joshua Goldstein 5,000 (3) 0.05 Marjorie Belson 28,000 (3) 0.3 Jonathan Belson 7,500 (3) 0.08 Jaclyn Belson 7,500 (3) 0.08 ______________ * Based upon 9,780,205 shares reported by the Company in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2002 to be outstanding as of October 25, 2002, adjusted to give effect to the issuance of shares underlying Jerome Belson's presently exercisable Common Stock purchase warrants. (1) Consists of 791,200 shares (including 256,000 shares issuable by the Company under presently exercisable warrants) as to which Mr. Belson has sole voting and investment power and 113,900 shares owned by his family members. Mr. Belson has been granted revocable powers of attorney over such 113,900 shares and, consequently, may be deemed to share voting and investment power over them. (2) Jerome Belson is the President and a director of the Foundation and, consequently, may be deemed to be a beneficial owner of such shares. Neither the filing of this Schedule nor any of its contents shall be deemed to be an admission that Mr. Belson owns any shares of the Company beneficially owned by the Foundation for purposes of Section 13(d) of the Securities Exchange Act of 1934 or for any other purpose. 14 (3) Voting and investment power over these shares is shared with Jerome Belson by reason of the named owner's grant to him of a power of attorney covering such shares.
Between September 1, 2002 and the date of this Amendment none of the persons filing this Schedule 13D has effected any transactions in the Common Stock of the Company except as set forth in Annex II hereto. All transactions reported in Annex II were open market transactions. Except as specifically stated in this Amendment, at the date of this Amendment to the best of the knowledge of the persons filing this Schedule none of the persons named in Annex I beneficially owns any Common Stock of the Company or has engaged in any transaction in the Common Stock between September 1, 2002 and the date of this Amendment. ITEM 7. MATERIAL TO BE FILED AS EXHIBITS is amended to add thereto the following: Exhibit 2 Written agreement relating to the filing of a joint acquisition statement. 15 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Dated: November 15, 2002 /s/ Jerome Belson -------------------------------- Jerome Belson /s/ Maxine Belson -------------------------------- Maxine Belson The Jerome Belson Foundation By: /s/ Jerome Belson -------------------------------- Jerome Belson, President /s/ Brianne Goldstein -------------------------------- Brianne Goldstein /s/ Toby Goldstein -------------------------------- Toby Goldstein /s/ Joshua Goldstein -------------------------------- Joshua Goldstein /s/ Marjorie Belson -------------------------------- Marjorie Belson /s/ Jonathan Belson -------------------------------- Jonathan Belson /s/ Jaclyn Belson -------------------------------- Jaclyn Belson 16 EXHIBIT 2 The undersigned hereby agree that the Schedule 13D and any amendments thereto filed by Jerome Belson, The Jerome Belson Foundation, Maxine Belson, Marjorie Belson, Brianne Goldstein, Joshua Goldstein, Toby Goldstein, Jaclyn Belson, Jonathan Belson and Matthew Belson under the Securities Exchange Act of 1934, (the "Act") reporting the beneficial ownership of shares of Common Stock of Elite Pharmaceuticals, Inc. may be filed with the Securities and Exchange Commission pursuant to Rule 13d-1(k)(1) under the Act on behalf of the undersigned. Dated: November 15, 2002 /s/ Jerome Belson -------------------------------- Jerome Belson /s/ Maxine Belson -------------------------------- Maxine Belson The Jerome Belson Foundation By: /s/ Jerome Belson -------------------------------- Jerome Belson, President /s/ Brianne Goldstein -------------------------------- Brianne Goldstein /s/ Toby Goldstein -------------------------------- Toby Goldstein /s/ Joshua Goldstein -------------------------------- Joshua Goldstein s/ Marjorie Belson -------------------------------- Marjorie Belson /s/ Jonathan Belson -------------------------------- Jonathan Belson /s/ Jaclyn Belson -------------------------------- Jaclyn Belson 17 ANNEX I The following is a list of the officers of The Jerome Belson Foundation: PRINCIPAL OCCUPATION NAME AND POSITION AND BUSINESS ADDRESS Jerome Belson Chairman of the Board of Jerome - President Belson Associates, Inc. 495 Broadway New York, New York 10012 Maxine Belson Housewife - Vice President 197 Rugby Road Brooklyn, New York 11226 I. Victor Belson Attorney - Vice President 7531 Monte Verde Lane West Palm Beach, Florida 33412 Brianne Goldstein Housewife - Treasurer 22 A Putnam Green Greenwich, CT 06830 Ruth Kessler Executive Secretary - Secretary Belson Associates, Inc. 495 Broadway New York, New York 10012 All of the above named individuals are citizens of the United States. 18
ANNEX II Date Transaction Price Shares - --------------- --------------- ------ ------ Jerome Belson - ------------- 10/04/02 Purchase $3.091 2,600 10/11/02 Purchase 3.060 5,000 10/24/02 Purchase 2.993 5,000 Jonathan Belson - --------------- 10/02/02 Purchase 2.898 1,000 10/03/02 Purchase 3.027 300 10/03/02 Purchase 3.017 1,200 Jaclyn Belson - --------------- 9/27/02 Purchase 3.161 1,000 9/27/02 Purchase 3.081 700 9/27/02 Purchase 3.152 500 10/02/02 Purchase 2.917 300
19 -----END PRIVACY-ENHANCED MESSAGE-----